Exciting news!

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm

This is really big news for the melanoma world. IPI is the 1st drug to be approved by FDA in 13 years for melanoma. This is great because now IPI is an option for people when they haven't been accepted to take part in a clincial trial.
I don't know if there will still be clincial trials going on since it has been approved.

It still might be a problem getting insurance companies to pay for the drug since it's rumored to cost about $30,000 a dose so for a 4dose infusion it will be
$120,000. I can't imagine many cancer patients have that kind of cash laying around.

For me personally I'll continue taking B-RAF until it stops working. But it is nice to know that IPI is an option if/when it gets to that point!